Urokinase treatment for severe neurological complications in a patient with thrombotic thrombocytopenic purpura

Sergio Vesconi; Martin Langer; Edoardo Rossi; Maria Benedetta Donati

doi:10.11569/wcjd.v22.i23.3371

Urokinase treatment for severe neurological complications in a patient with thrombotic thrombocytopenic purpura

Sergio Vesconi, Martin Langer, Edoardo Rossi, Maria Benedetta Donati

Research output: Contribution to journal › Article › peer-review

Abstract

In a patieni with thrombotic thrombocytopenic purpura (TTP) severe neurological complications leading to coma were repeatedly reversed by treatment with urokinase. Although the therapeutic modalities for TTP still appear to be a matter of debate, thrombolytic treatment could be considered in TTP patients with severe organ involvement before the corresponding function is completely compromised.

Original language	English
Pages (from-to)	289-295
Number of pages	7
Journal	Pathophysiology of Haemostasis and Thrombosis
Volume	10
Issue number	5
DOIs	https://doi.org/10.11569/wcjd.v22.i23.3371
Publication status	Published - 1981

Keywords

Neurological com cations
Thrombotic thrombocytopenic purpura
Urokinase

ASJC Scopus subject areas

Hematology
Physiology (medical)

Access to Document

10.11569/wcjd.v22.i23.3371

Fingerprint Dive into the research topics of 'Urokinase treatment for severe neurological complications in a patient with thrombotic thrombocytopenic purpura'. Together they form a unique fingerprint.

Cite this

@article{47cb05575a1a45d68f37292c1a95d0da,

title = "Urokinase treatment for severe neurological complications in a patient with thrombotic thrombocytopenic purpura",

abstract = "In a patieni with thrombotic thrombocytopenic purpura (TTP) severe neurological complications leading to coma were repeatedly reversed by treatment with urokinase. Although the therapeutic modalities for TTP still appear to be a matter of debate, thrombolytic treatment could be considered in TTP patients with severe organ involvement before the corresponding function is completely compromised.",

keywords = "Neurological com cations, Thrombotic thrombocytopenic purpura, Urokinase",

author = "Sergio Vesconi and Martin Langer and Edoardo Rossi and Donati, {Maria Benedetta}",

year = "1981",

doi = "10.11569/wcjd.v22.i23.3371",

language = "English",

volume = "10",

pages = "289--295",

journal = "Pathophysiology of Haemostasis and Thrombosis",

issn = "1424-8832",

publisher = "S. Karger AG",

number = "5",

}

TY - JOUR

T1 - Urokinase treatment for severe neurological complications in a patient with thrombotic thrombocytopenic purpura

AU - Vesconi, Sergio

AU - Langer, Martin

AU - Rossi, Edoardo

AU - Donati, Maria Benedetta

PY - 1981

Y1 - 1981

N2 - In a patieni with thrombotic thrombocytopenic purpura (TTP) severe neurological complications leading to coma were repeatedly reversed by treatment with urokinase. Although the therapeutic modalities for TTP still appear to be a matter of debate, thrombolytic treatment could be considered in TTP patients with severe organ involvement before the corresponding function is completely compromised.

AB - In a patieni with thrombotic thrombocytopenic purpura (TTP) severe neurological complications leading to coma were repeatedly reversed by treatment with urokinase. Although the therapeutic modalities for TTP still appear to be a matter of debate, thrombolytic treatment could be considered in TTP patients with severe organ involvement before the corresponding function is completely compromised.

KW - Neurological com cations

KW - Thrombotic thrombocytopenic purpura

KW - Urokinase

UR - http://www.scopus.com/inward/record.url?scp=0019413847&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019413847&partnerID=8YFLogxK

U2 - 10.11569/wcjd.v22.i23.3371

DO - 10.11569/wcjd.v22.i23.3371

M3 - Article

C2 - 7024052

AN - SCOPUS:0019413847

VL - 10

SP - 289

EP - 295

JO - Pathophysiology of Haemostasis and Thrombosis

JF - Pathophysiology of Haemostasis and Thrombosis

SN - 1424-8832

IS - 5

ER -